ArticleFrontiers in oncology2021

Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer.

Po-Fu Yueh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.